Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SWEFOT: TNF-Blockade + MTX vs Triple Therapy in Early RA
NCT00764725Phase 4Completed
- Sponsor
- Karolinska Institutet
- Start
- Dec 2002
- Primary completion
- Apr 2007
- Modality
- Monoclonal Antibodies
01
Overview
A Phase 4 trial of infliximab in rheumatoid arthritis (RA), sponsored by Karolinska Institutet. Started Dec 2002; status: completed.
02
Drugs
infliximab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT00764725.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00764725.